Drug Approval | April 07, 2022
Lupin launches Merzee capsules in the United States
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
NEJM study shows strong protection across strains
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
This is an exciting and meaningful milestone for GRIN Therapeutics
Fresenius Kabi's approved generic therapy addresses acute symptomatic hypocalcemia and targets a US market valued at nearly $71 million
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Keeps Halo Pharma to drive independent growth
Subscribe To Our Newsletter & Stay Updated
